SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 6.060-2.5%10:00 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (7)7/7/1997 12:40:00 PM
From: Boyce Burge of 557
 
The area of gene therapy (GT) is sleepy in terms of share price, but in terms of progress there is satisfying new science on all fronts. I bought 500 shares of Cell Genesys last week on their announcement of factor IX production in mouse liver using AAV vectors. The mouse made human factor 9 for 9+ months!

The market is chosing to value big pharma this year(DRG index up 35%+) but I believe the pendulum will swing to a select group of GT companies soon. I predict that ARIA, CEGE, and TGEN will double in 12 months or so.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext